Bio-Techne (TECH) Competitors $64.92 -0.57 (-0.87%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$64.96 +0.03 (+0.05%) As of 02/21/2025 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends TECH vs. A, MTD, WAT, ILMN, CRL, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Bio-Techne stock or one of its competitors? The main competitors of Bio-Techne include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Bio-Techne vs. Agilent Technologies Mettler-Toledo International Waters Illumina Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Bio-Techne (NASDAQ:TECH) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, community ranking, valuation, dividends and media sentiment. Does the MarketBeat Community believe in TECH or A? Agilent Technologies received 468 more outperform votes than Bio-Techne when rated by MarketBeat users. Likewise, 71.05% of users gave Agilent Technologies an outperform vote while only 62.46% of users gave Bio-Techne an outperform vote. CompanyUnderperformOutperformBio-TechneOutperform Votes39662.46% Underperform Votes23837.54% Agilent TechnologiesOutperform Votes86471.05% Underperform Votes35228.95% Do analysts rate TECH or A? Bio-Techne presently has a consensus price target of $84.29, indicating a potential upside of 29.83%. Agilent Technologies has a consensus price target of $144.38, indicating a potential upside of 6.69%. Given Bio-Techne's higher possible upside, research analysts clearly believe Bio-Techne is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bio-Techne 0 Sell rating(s) 4 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50Agilent Technologies 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has more volatility and risk, TECH or A? Bio-Techne has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500. Is TECH or A more profitable? Agilent Technologies has a net margin of 19.80% compared to Bio-Techne's net margin of 13.22%. Agilent Technologies' return on equity of 25.43% beat Bio-Techne's return on equity.Company Net Margins Return on Equity Return on Assets Bio-Techne13.22% 12.73% 9.75% Agilent Technologies 19.80%25.43%13.79% Do institutionals & insiders have more ownership in TECH or A? 99.0% of Bio-Techne shares are held by institutional investors. Comparatively, 87.4% of Agilent Technologies shares are held by institutional investors. 3.9% of Bio-Techne shares are held by insiders. Comparatively, 0.3% of Agilent Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media favor TECH or A? In the previous week, Agilent Technologies had 2 more articles in the media than Bio-Techne. MarketBeat recorded 25 mentions for Agilent Technologies and 23 mentions for Bio-Techne. Agilent Technologies' average media sentiment score of 1.26 beat Bio-Techne's score of 0.29 indicating that Agilent Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Techne 8 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Agilent Technologies 18 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is TECH or A a better dividend stock? Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.5%. Agilent Technologies pays an annual dividend of $0.99 per share and has a dividend yield of 0.7%. Bio-Techne pays out 32.3% of its earnings in the form of a dividend. Agilent Technologies pays out 22.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Agilent Technologies is clearly the better dividend stock, given its higher yield and lower payout ratio. Which has preferable earnings & valuation, TECH or A? Agilent Technologies has higher revenue and earnings than Bio-Techne. Agilent Technologies is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBio-Techne$1.16B8.85$168.10M$0.9965.58Agilent Technologies$6.51B5.93$1.29B$4.4230.62 SummaryAgilent Technologies beats Bio-Techne on 13 of the 19 factors compared between the two stocks. Get Bio-Techne News Delivered to You Automatically Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TECH vs. The Competition Export to ExcelMetricBio-TechneBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.35B$3.12B$5.82B$9.09BDividend Yield0.49%1.57%4.77%3.84%P/E Ratio65.5814.9418.9215.38Price / Sales8.85361.02453.2984.08Price / Cash28.30177.4343.8437.22Price / Book4.943.687.644.65Net Income$168.10M-$71.72M$3.18B$245.69M7 Day Performance-1.55%-2.46%-1.95%-2.67%1 Month Performance-17.52%-0.25%-0.23%-2.16%1 Year Performance-9.53%-12.31%16.69%12.90% Bio-Techne Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TECHBio-Techne4.9205 of 5 stars$64.92-0.9%$84.29+29.8%-9.5%$10.35B$1.16B65.583,100Analyst DowngradeInsider TradeAAgilent Technologies4.0902 of 5 stars$134.57-1.4%$144.38+7.3%0.0%$38.39B$6.51B30.4517,900Upcoming EarningsDividend AnnouncementNews CoveragePositive NewsMTDMettler-Toledo International3.8998 of 5 stars$1,273.44-1.8%$1,368.00+7.4%+7.7%$26.64B$3.87B31.4217,300Positive NewsWATWaters3.9893 of 5 stars$369.71-2.5%$390.40+5.6%+13.6%$21.95B$2.96B35.287,900ILMNIllumina4.7737 of 5 stars$100.24-1.5%$159.45+59.1%-30.9%$15.90B$4.37B-13.059,300CRLCharles River Laboratories International4.7854 of 5 stars$152.07-0.7%$200.79+32.0%-32.3%$7.78B$4.13B19.0321,800Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews CoverageBIOBio-Rad Laboratories4.7956 of 5 stars$276.55-9.7%$395.20+42.9%-17.5%$7.74B$2.57B-10.128,030High Trading VolumeBRKRBruker4.857 of 5 stars$50.04-2.2%$70.50+40.9%-38.0%$7.59B$2.96B24.069,707PACBPacific Biosciences of California2.3208 of 5 stars$1.85+25.0%$2.85+54.3%-69.7%$506.64M$200.52M-1.27730Analyst ForecastOptions VolumeAnalyst RevisionNews CoverageGap UpHigh Trading VolumeHBIOHarvard Bioscience2.2268 of 5 stars$1.35+1.5%N/A-77.7%$58.89M$112.25M-4.09490News CoverageGap DownTMOThermo Fisher Scientific4.7279 of 5 stars$532.580.0%$658.00+23.5%-3.7%$203.71B$42.88B32.22122,000Dividend IncreaseAnalyst RevisionPositive News Related Companies and Tools Related Companies A Competitors MTD Competitors WAT Competitors ILMN Competitors CRL Competitors BIO Competitors BRKR Competitors PACB Competitors HBIO Competitors TMO Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TECH) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Techne Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Techne With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
